ZYLOPRIM

This brand name is authorized in Australia, Canada, Mexico, United States, South Africa

Active ingredients

The drug ZYLOPRIM contains one active pharmaceutical ingredient (API):

1 Allopurinol UNII 63CZ7GJN5I - ALLOPURINOL

Allopurinol is a xanthine-oxidase inhibitor. Allopurinol and its main metabolite oxipurinol lower the level of uric acid in plasma and urine by inhibition of xanthine oxidase, the enzyme catalyzing the oxidation of hypoxanthine to xanthine and xanthine to uric acid. Read about Allopurinol

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
ZYLOPRIM Tablet	FDA, National Drug Code (US)	MPI, US: SPL/Old

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
M04AA01	Allopurinol	M Musculo-skeletal system → M04 Antigout preparations → M04A Antigout preparations → M04AA Preparations inhibiting uric acid production
Discover more medicines within M04AA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 2600W, 2604C
Country: CA	Health Products and Food Branch	Identifier(s): 00402796, 00402818, 00479799
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 86270
Country: US	FDA, National Drug Code	Identifier(s): 67046-681, 70199-015, 70199-016
Country: ZA	Health Products Regulatory Authority	Identifier(s): G/3.3/51